1. US Food and Drug Administration. FDA approves first biosimilar product Zarxio. Retrieved from: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm436648.htm . Accessed 6 Mar 2015.
2. US Food and Drug Administration. FDA approves Inflectra, a biosimilar to Remicade. Retrieved from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm494227.htm . Accessed 5 Apr 2016.
3. US Food and Drug Administration. FDA approved Erelzi, a biosimilar to Enbrel. Retrieved from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm518639.htm . Accessed 30 Aug 2016.
4. Eastern Research Group, Inc. Review of biosimilar product applications: study of workload volume and full costs. Retrieved from: http://www.fda.gov/downloads/ForIndustry/UserFees/BiosimilarUserFeeActBsUFA/UCM488846.pdf . Accessed 24 Feb 2016.
5. IMS Health. The Impact of Biosimilar Competition. Retrieved from: http://ec.europa.eu/growth/tools-databases/newsroom/cf/itemdetail.cfm?item_id=8854 . Accessed 20 June 2016.